Advances and Personalized Approaches in the Frontline Treatment of T-Cell Lymphomas
Peripheral T-cell lymphomas (PTCLs) are a rare and heterogenous subset of non-Hodgkin lymphoma characterized by an aggressive clinical course. Historically, the treatment of PTCLs have been analogous to that of aggressive B-cell lymphomas; however, it has been well-established that overall responses...
Main Authors: | Mathew G. Angelos, Hatcher J. Ballard, Stefan K. Barta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/2/267 |
Similar Items
-
Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma
by: Pelcovits A, et al.
Published: (2023-09-01) -
Editorial: Advances in the treatment of Hodgkin lymphoma
by: Matthew Mei, et al.
Published: (2023-02-01) -
Evans Syndrome as a Possible Complication of Brentuximab Vedotin Therapy for Peripheral T Cell Lymphoma
by: Ruxandra Irimia, et al.
Published: (2023-03-01) -
SUCCESSFUL USE OF BRENTUXIMAB VEDOTIN IN THE TREATMENT OF PROGRESSIVE PERIPHERAL UNSPECIFIED T-CELL LYMPHOMA IN AN ELDERLY FEMALE PATIENT
by: L. G. Gorenkova, et al.
Published: (2017-06-01) -
Composite Angioimmunoblastic T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma Presenting with Distributive Shock
by: Nisha Hariharan, et al.
Published: (2023-11-01)